Literature DB >> 33905807

Sex differences in the magnitude of diabetic ocular surface complications: Role of serum OGF.

Indira Purushothaman1, Ian S Zagon1, Joseph W Sassani2, Shouhao Zhou3, Patricia J McLaughlin4.   

Abstract

Diabetes is associated with dysregulation of the Opioid Growth Factor (OGF) - OGF receptor (OGFr) regulatory pathway leading to elevated OGF levels in serum and tissues. This study was designed to investigate the role of sex on the magnitude of ocular surface complications by direct comparison of male and female type 1 diabetic (T1D) rats. Male and female adult Sprague-Dawley rats were rendered T1D; a cohort of T1D male and female rats received insulin (=T1D-INS). Tear production, corneal surface sensitivity, as well as serum levels of estrogen, testosterone, OGF and OGFr were measured. Multivariate analyses were performed for correlations between sex, condition and magnitude of ocular surface alterations. Significant differences were noted in all parameters tested between male and female Normal, T1D, and T1D-INS animals over the 8-week observation period. Multivariate analyses revealed that the magnitude of complications is greater in female T1D rats and has a strong negative correlation with serum estrogen and OGF. Ocular surface complications associated with T1D have an earlier onset and greater magnitude in female T1D rats than male diabetic animals, and are related to elevated levels of OGF.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Diabetes; Keratopathy; Ocular surface complications; Sex

Mesh:

Substances:

Year:  2021        PMID: 33905807      PMCID: PMC8184618          DOI: 10.1016/j.physbeh.2021.113436

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  31 in total

1.  Reepithelialization of the human cornea is regulated by endogenous opioids.

Authors:  I S Zagon; J W Sassani; P J McLaughlin
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-01       Impact factor: 4.799

2.  Tungstate treatment improves Leydig cell function in streptozotocin-diabetic rats.

Authors:  Joan Ballester; Jorge Domínguez; M Carmen Muñoz; Meritxell Sensat; Teresa Rigau; Joan J Guinovart; Joan E Rodríguez-Gil
Journal:  J Androl       Date:  2005 Nov-Dec

3.  Plasma met-enkephalin in type I diabetes.

Authors:  M Negri; G Tonnarini; M D'Alessandro; F Fallucca
Journal:  Metabolism       Date:  1992-05       Impact factor: 8.694

4.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.

Authors:  N H Cho; J E Shaw; S Karuranga; Y Huang; J D da Rocha Fernandes; A W Ohlrogge; B Malanda
Journal:  Diabetes Res Clin Pract       Date:  2018-02-26       Impact factor: 5.602

5.  Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance.

Authors:  Anil K Bidani; Maria Picken; Rifat Hacioglu; Geoffrey Williamson; Karen A Griffin
Journal:  Am J Physiol Renal Physiol       Date:  2006-09-12

6.  Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats.

Authors:  Matthew S Klocek; Joseph W Sassani; Patricia J McLaughlin; Ian S Zagon
Journal:  Exp Eye Res       Date:  2009-07-01       Impact factor: 3.467

7.  Diabetic nephropathy is associated with decreased circulating estradiol levels and imbalance in the expression of renal estrogen receptors.

Authors:  Corinne C Wells; Shahla Riazi; Richard W Mankhey; Faizah Bhatti; Carolyn Ecelbarger; Christine Maric
Journal:  Gend Med       Date:  2005-12

8.  Streptozotocin-induced diabetes in the rat is associated with changes in vaginal hemodynamics, morphology and biochemical markers.

Authors:  Noel N Kim; Miljan Stankovic; Tulay T Cushman; Irwin Goldstein; Ricardo Munarriz; Abdulmaged M Traish
Journal:  BMC Physiol       Date:  2006-05-30

9.  Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes.

Authors:  Patricia J McLaughlin; Joseph W Sassani; Michelle B Titunick; Ian S Zagon
Journal:  BMC Ophthalmol       Date:  2019-01-28       Impact factor: 2.209

Review 10.  From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research.

Authors:  Radia Marium Modhumi Khan; Zoey Jia Yu Chua; Jia Chi Tan; Yingying Yang; Zehuan Liao; Yan Zhao
Journal:  Medicina (Kaunas)       Date:  2019-08-29       Impact factor: 2.430

View more
  2 in total

Review 1.  Opioids and Ocular Surface Pathology: A Literature Review of New Treatments Horizons.

Authors:  Celia García-López; Carmen Gómez-Huertas; José-María Sánchez-González; Davide Borroni; Marina Rodríguez-Calvo-de-Mora; Vito Romano; Rahul Rachwani-Anil; Juan-Francisco Ramos-López; Santiago Ortiz-Pérez; Carlos Rocha-de-Lossada
Journal:  J Clin Med       Date:  2022-03-04       Impact factor: 4.241

Review 2.  Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin.

Authors:  Indira Purushothaman; Ian S Zagon; Joseph W Sassani; Patricia J McLaughlin
Journal:  Biochem Pharmacol       Date:  2021-07-26       Impact factor: 6.100

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.